Marla Persky, a director at Xeris Biopharma Holdings ($XERS), made one open market sale of company shares in the last year, totaling $119,610 on September 11, 2025. She had no open market purchases during this period. Her sales volume ranks 9,315th out of 11,678 individual insiders, well below the average of $8.6 million per seller across about 6.4 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 11, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | PERSKY MARLA | Director | S | Common Stock | 15500 | $7.72 | 148,370.0000 | 146,772,758 | 9.46% | 0.01% |
| June 4, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | PERSKY MARLA | Director | A | Common Stock | 50000 | $0.00 | 163,870.0000 | 146,772,758 | 43.91% | 0.03% |
| June 5, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | PERSKY MARLA | Director | A | Common Stock | 50000 | $0.00 | 113,870.0000 | 137,674,857 | 78.28% | 0.04% |